These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 2665440)
1. Rationale for the development of an engineered sporozoite malaria vaccine. Nussenzweig V; Nussenzweig RS Adv Immunol; 1989; 45():283-334. PubMed ID: 2665440 [No Abstract] [Full Text] [Related]
2. Recent advances in the development of a sporozoite vaccine for malaria. Nussenzweig V; Nussenzweig RS Asian Pac J Allergy Immunol; 1984 Dec; 2(2):289-92. PubMed ID: 6398085 [No Abstract] [Full Text] [Related]
3. Vaccine development. Which way for malaria? Cox FE Nature; 1988 Feb; 331(6156):486-7. PubMed ID: 3124000 [No Abstract] [Full Text] [Related]
4. Progress towards a malaria vaccine. Cohen S J R Coll Physicians Lond; 1985 Oct; 19(4):210-3. PubMed ID: 2415702 [No Abstract] [Full Text] [Related]
5. Selecting candidate antigens for malaria vaccines. Kidson C; Saul A; Schofield L; Upcroft J; Don M; Read D; Myler P; Castelino D; Chiu S; Ingram L Asian Pac J Allergy Immunol; 1984 Dec; 2(2):325-8. PubMed ID: 6085274 [No Abstract] [Full Text] [Related]
6. Naked DNA for malaria vaccines. Fricker J Mol Med Today; 1996 Mar; 2(3):91. PubMed ID: 8846464 [No Abstract] [Full Text] [Related]
7. Towards a blood-stage vaccine for malaria: are we following all the leads? Good MF Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819 [TBL] [Abstract][Full Text] [Related]
10. Nucleic acid malaria vaccines. Current status and potential. Hoffman SL; Doolan DL; Sedegah M; Gramzinski R; Wang H; Gowda K; Hobart P; Margalith M; Norman J; Hedstrom RC Ann N Y Acad Sci; 1995 Nov; 772():88-94. PubMed ID: 8546416 [No Abstract] [Full Text] [Related]
11. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Nardin EH; Nussenzweig RS Annu Rev Immunol; 1993; 11():687-727. PubMed ID: 8476576 [TBL] [Abstract][Full Text] [Related]
12. Steps towards a malaria vaccine. Hommel M Res Immunol; 1991 Oct; 142(8):618-31. PubMed ID: 1817288 [No Abstract] [Full Text] [Related]
13. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Good MF; Kumar S; Miller LH Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406 [No Abstract] [Full Text] [Related]
14. Towards a malaria vaccine: what is in sight? del Giudice G Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171 [No Abstract] [Full Text] [Related]
15. Development of sporozoite vaccines for malaria. Chulay JD Trans R Soc Trop Med Hyg; 1989; 83 Suppl():61-6. PubMed ID: 2696162 [TBL] [Abstract][Full Text] [Related]
16. Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines. Cockburn I Methods Mol Biol; 2013; 923():465-79. PubMed ID: 22990798 [TBL] [Abstract][Full Text] [Related]